CSIMarket
 


Scpharmaceuticals Inc   (SCPH)
Other Ticker:  
 

Scpharmaceuticals Inc 's Quick Ratio

SCPH's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




SCPH Quick Ratio (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Current Liabilities Change 20.97 % 31.43 % 50.6 % 62.17 % 103.11 %
Y / Y Cash & cash equivalent Change -46.74 % -37.96 % -32.09 % -28.37 % -25.8 %
Quick Ratio MRQ 2.73 3.73 4.73 5.24 6.19
Overall Ranking # # # # #
Seq. Current Liabilities Change 10.64 % 8.45 % -3.83 % 4.83 % 20.21 %
Seq. Cash & cash equivalent Change -19.1 % -14.62 % -13.1 % -11.27 % -5.76 %



Quick Ratio third quarter 2022 Comment
Due to increase in Current Liabilities in the third quarter 2022, Quick Ratio fell to 2.73 above Scpharmaceuticals Inc average.

Within Major Pharmaceutical Preparations industry Scpharmaceuticals Inc booked the highest Quick Ratio than Scpharmaceuticals Inc in the third quarter 2022. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are SCPH Segments?
See Quick Ratio SCPH on the trailing twelve month basis
Quick Ratio third quarter 2022 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #


Quick Ratio Statistics
High Average Low
0 0 0
 




Financial Statements
Scpharmaceuticals Inc 's Current Liabilities $ 17 Millions Visit SCPH's Balance sheet
Scpharmaceuticals Inc 's Cash & cash equivalent $ 45 Millions Visit SCPH's Balance sheet
Source of SCPH's Sales Visit SCPH's Sales by Geography


Cumulative Scpharmaceuticals Inc 's Quick Ratio

SCPH's Quick Ratio for the trailling 12 Months

SCPH Quick Ratio

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Current Liabilities TTM Growth 20.97 % 31.43 % 50.6 % 62.17 % 103.11 %
Y / Y Cash & cash equivalent TTM Growth -46.74 % -37.96 % -32.09 % -28.37 % -25.8 %
Quick Ratio TTM 4.05 4.95 5.92 7.12 8.72
Total Ranking TTM # 567 # 646 # 751 # 414 # 375
Seq. Current Liabilities TTM Growth 10.64 % 8.45 % -3.83 % 4.83 % 20.21 %
Seq. Cash & cash equivalent TTM Growth -19.1 % -14.62 % -13.1 % -11.27 % -5.76 %


TTM Quick Ratio Comment
On the trailing twelve months basis Due to increase in Current Liabilities in the III. Quarter to $16.58 millions, average cumulative Quick Ratio decreased to 4.05 below the Scpharmaceuticals Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 218 other companies have achieved higher Quick Ratio than Scpharmaceuticals Inc . While overall ranking remained unchanged compare to previous quarter at no. 567.

Explain Quick Ratio?
What are SCPH Segments?
See Quick Ratio SCPH on the trailing twelve month basis

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 219
Healthcare Sector # 384
Within the Market # 567


TTM Quick Ratio Statistics
High Average Low
16.57 9.77 3.92
(Sep 30 2020)   (Sep 30 2022)




Companies with similar Quick Ratio in the quarter ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Quick RatioSep 30 2022 MRQ Cash & cash equivalentSep 30 2022 MRQ Current Liabilities
Monopar Therapeutics Inc   7.48 $ 14.316  Millions$ 1.914  Millions
Provention Bio Inc   7.39 $ 185.521  Millions$ 25.118  Millions
Lexicon Pharmaceuticals Inc   7.38 $ 136.203  Millions$ 18.445  Millions
Renovorx Inc   7.36 $ 8.114  Millions$ 1.102  Millions
Verona Pharma Plc  7.34 $ 231.701  Millions$ 31.559  Millions
Summit Therapeutics Inc   7.31 $ 121.971  Millions$ 16.682  Millions
Protagonist Therapeutics inc   7.28 $ 267.437  Millions$ 36.754  Millions
Geovax Labs Inc   7.24 $ 34.677  Millions$ 4.789  Millions
Zai Lab Limited  7.20 $ 1,119.476  Millions$ 155.548  Millions
Evoke Pharma Inc   7.11 $ 12.350  Millions$ 1.738  Millions
Bolt Biotherapeutics Inc   7.08 $ 171.130  Millions$ 24.174  Millions
Assembly Biosciences Inc   7.03 $ 108.651  Millions$ 15.461  Millions
Rain Therapeutics inc   6.97 $ 90.708  Millions$ 13.013  Millions
Roivant Sciences Ltd   6.93 $ 1,599.021  Millions$ 230.744  Millions
Leap Therapeutics inc   6.92 $ 78.308  Millions$ 11.318  Millions
Scynexis Inc   6.87 $ 96.090  Millions$ 13.995  Millions
Foghorn Therapeutics Inc   6.77 $ 373.498  Millions$ 55.210  Millions
Angion Biomedica Corp  6.74 $ 55.143  Millions$ 8.182  Millions
Glycomimetics Inc   6.67 $ 51.677  Millions$ 7.748  Millions
Vincerx Pharma Inc   6.63 $ 65.975  Millions$ 9.950  Millions
Phio Pharmaceuticals Corp   6.60 $ 14.484  Millions$ 2.194  Millions
Blue Water Vaccines Inc   6.58 $ 29.137  Millions$ 4.431  Millions
Nektar Therapeutics  6.51 $ 546.387  Millions$ 83.989  Millions
Blueprint Medicines Corporation  6.48 $ 1,136.965  Millions$ 175.510  Millions
Syros Pharmaceuticals Inc   6.36 $ 244.481  Millions$ 38.424  Millions
Tff Pharmaceuticals Inc   6.33 $ 13.147  Millions$ 2.077  Millions
Immunic Inc   6.32 $ 72.771  Millions$ 11.514  Millions
Bio path Holdings Inc  6.20 $ 13.650  Millions$ 2.201  Millions
Ngm Biopharmaceuticals Inc   6.18 $ 300.150  Millions$ 48.596  Millions
Selecta Biosciences Inc  6.17 $ 146.442  Millions$ 23.728  Millions

Date modified: 2022-11-13T02:37:57+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ASH's Profile

Stock Price

ASH's Financials

Business Description

Fundamentals

Charts & Quotes

ASH's News

Suppliers

ASH's Competitors

Customers & Markets

Economic Indicators

ASH's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071